Search research articles
Contact Us
Filters
Showing results (1-10 of 353) with videos related to
Page
of 36
Sort By:
Nature Reviews. Cardiology
|
December 5, 2013
Interventional cardiology: does an optimal antithrombotic regimen for PCI exist?
A Michael Lincoff
Lancet (London, England)
|
August 19, 2014
Heparin monotherapy for percutaneous coronary intervention?
A Michael Lincoff
JACC. Cardiovascular Interventions
|
October 24, 2015
What Role for Glycoprotein IIb/IIIa Inhibition in Contemporary Coronary Intervention?
A Michael Lincoff
Nature Clinical Practice. Cardiovascular Medicine
|
May 27, 2006
How do unfractionated and low-molecular-weight heparin compare after ST-segment elevation MI?
A Michael Lincoff
American Heart Journal
|
October 18, 2003
Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
A Michael Lincoff
The Journal of Invasive Cardiology
|
February 16, 2002
Management of acute coronary syndromes with emphasis on new information for the treatment of ST-segment elevation acute myocardial infarction
A Michael Lincoff
The Journal of Invasive Cardiology
|
February 16, 2002
The GUSTO-V clinical trial
A Michael Lincoff
The Journal of Invasive Cardiology
|
April 12, 2013
Glycoprotein IIb/IIIa inhibitors
A Michael Lincoff
Circulation
|
March 26, 2003
Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade
A Michael Lincoff
Cleveland Clinic Journal of Medicine
|
April 3, 2014
Managing acute coronary syndromes: decades of progress
A Michael Lincoff
Page
of 36
Search research articles
Search
Showing results (1-10 of 353) with videos related to
Sort By:
Page
of 36
Nature Reviews. Cardiology
|
December 5, 2013
Interventional cardiology: does an optimal antithrombotic regimen for PCI exist?
A Michael Lincoff
Lancet (London, England)
|
August 19, 2014
Heparin monotherapy for percutaneous coronary intervention?
A Michael Lincoff
JACC. Cardiovascular Interventions
|
October 24, 2015
What Role for Glycoprotein IIb/IIIa Inhibition in Contemporary Coronary Intervention?
A Michael Lincoff
Nature Clinical Practice. Cardiovascular Medicine
|
May 27, 2006
How do unfractionated and low-molecular-weight heparin compare after ST-segment elevation MI?
A Michael Lincoff
American Heart Journal
|
October 18, 2003
Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
A Michael Lincoff
The Journal of Invasive Cardiology
|
February 16, 2002
Management of acute coronary syndromes with emphasis on new information for the treatment of ST-segment elevation acute myocardial infarction
A Michael Lincoff
The Journal of Invasive Cardiology
|
February 16, 2002
The GUSTO-V clinical trial
A Michael Lincoff
The Journal of Invasive Cardiology
|
April 12, 2013
Glycoprotein IIb/IIIa inhibitors
A Michael Lincoff
Circulation
|
March 26, 2003
Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade
A Michael Lincoff
Cleveland Clinic Journal of Medicine
|
April 3, 2014
Managing acute coronary syndromes: decades of progress
A Michael Lincoff
Page
of 36